Serotonin-norepinephrine reuptake inhibitor (SNRI) medications are antidepressant drugs that doctors may prescribe to treat depression, anxiety, and some forms of chronic pain. SNRIs may improve mood ...

Atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI), may improve outcomes for patients with both attention-deficit/hyperactivity disorder (ADHD) and ...

Everybody's different — and everyone's depression is different, too. If you and your doctor decide to try antidepressant medications to help treat your depression, you’ll work together to find one ...

Switching from an SSRI to an SNRI typically involves gradually tapering off the SSRI under a doctor’s guidance and starting the SNRI at a low dose. Switching from a selective serotonin reuptake ...

Pfizer has announced positive topline results from a phase 4 efficacy study of the selective serotonin and norepinephrine reuptake inhibitor (SNRI) desvenlafaxine (Pristiq) extended-release tablets ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...

In treatment-resistant depression, commonly defined as a lack of response to two or more consecutive treatments during the current depressive episode, the percentage of patients with remission is low ...

Approximately one in nine American adults takes an antidepressant (AD), the prescriptions written not by psychiatrists but by primary-care clinicians, internists, family physicians, and nurse ...

Desvenlafaxine, the major active metabolite of venlafaxine (Effexor XR, also from Wyeth), is a potent and selective SNRI. The increase in the effects of these neurotransmitters in the central nervous ...